These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development]. Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M. Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013 [Abstract] [Full Text] [Related]
4. The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Kato M, Atsumi T, Oku K, Amengual O, Nakagawa H, Fujieda Y, Otomo K, Horita T, Yasuda S, Koike T. Lupus; 2013 Jul; 22(8):761-71. PubMed ID: 23817509 [Abstract] [Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
6. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS. Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [Abstract] [Full Text] [Related]
7. Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Nikolopoulos D, Loukogiannaki C, Sentis G, Garantziotis P, Manolakou T, Kapsala N, Nikoloudaki M, Pieta A, Flouda S, Parodis I, Bertsias G, Fanouriakis A, Filia A, Boumpas DT. Ann Rheum Dis; 2024 Aug 27; 83(9):1132-1143. PubMed ID: 38609158 [Abstract] [Full Text] [Related]
8. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS. Ter Arkh; 2000 Aug 27; 72(5):34-8. PubMed ID: 11109617 [Abstract] [Full Text] [Related]
9. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. J Rheumatol; 2009 Jun 27; 36(6):1195-9. PubMed ID: 19447935 [Abstract] [Full Text] [Related]
10. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R. Arterioscler Thromb Vasc Biol; 2014 Mar 27; 34(3):661-8. PubMed ID: 24436371 [Abstract] [Full Text] [Related]
11. Antiphospholipid syndrome: 30 years and our contribution. Koike T. Int J Rheum Dis; 2015 Feb 27; 18(2):233-41. PubMed ID: 25524556 [Abstract] [Full Text] [Related]
12. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome]. Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG. Ter Arkh; 2006 Feb 27; 78(5):21-31. PubMed ID: 16889045 [Abstract] [Full Text] [Related]
13. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]. Sarzi-Puttini P, Atzeni F, Carrabba M. Minerva Med; 2003 Apr 27; 94(2):63-70. PubMed ID: 12858154 [Abstract] [Full Text] [Related]
14. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA. J Rheumatol; 2000 Dec 27; 27(12):2833-7. PubMed ID: 11128672 [Abstract] [Full Text] [Related]
15. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I, Levi Y, Godard G, Shoenfeld Y. Harefuah; 2001 Jun 27; 140(6):495-500, 565. PubMed ID: 11420848 [Abstract] [Full Text] [Related]
16. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I. Rheumatol Int; 2002 Aug 27; 22(4):142-7. PubMed ID: 12172952 [Abstract] [Full Text] [Related]
17. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus. Singh NK, Agrawal A, Singh MN, Kumar V, Godhra M, Gupta A, Yadav DP, Usha, Singh RG, Singh TB. J Assoc Physicians India; 2013 Sep 27; 61(9):623-6. PubMed ID: 24772699 [Abstract] [Full Text] [Related]
18. Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches. Lopez-Pedrera C, Aguirre-Zamorano MÁ, Pérez-Sánchez C. Med Clin (Barc); 2017 Aug 22; 149(4):160-169. PubMed ID: 28619369 [Abstract] [Full Text] [Related]
19. Antiphospholipid antibody tests: spreading the net. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Nov 22; 64(11):1639-43. PubMed ID: 15817655 [Abstract] [Full Text] [Related]
20. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C. Front Immunol; 2019 Nov 22; 10():764. PubMed ID: 31040845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]